Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Simulating the Impact of Elevated Levels of Interleukin-6 on the Pharmacokinetics of Various CYP450 Substrates in Patients with Neuromyelitis Optica or Neuromyelitis Optica Spectrum Disorders in Different Ethnic Populations.

Machavaram KK, Endo-Tsukude C, Terao K, Gill KL, Hatley OJ, Gardner I, Parrott N, Ducray PS.

AAPS J. 2019 Mar 18;21(3):42. doi: 10.1208/s12248-019-0309-y.

PMID:
30887238
2.

Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis.

Burt HJ, Riedmaier AE, Harwood MD, Crewe HK, Gill KL, Neuhoff S.

Drug Metab Dispos. 2016 Oct;44(10):1550-61. doi: 10.1124/dmd.116.071183. Epub 2016 Aug 4.

3.

Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.

Gill KL, Machavaram KK, Rose RH, Chetty M.

Clin Pharmacokinet. 2016 Jul;55(7):789-805. doi: 10.1007/s40262-015-0361-4. Review.

PMID:
26818483
4.
5.

Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site.

Musther H, Gill KL, Chetty M, Rostami-Hodjegan A, Rowland M, Jamei M.

AAPS J. 2015 Sep;17(5):1268-79. doi: 10.1208/s12248-015-9796-7. Epub 2015 Jun 23.

6.

Organized polysaccharide fibers as stable drug carriers.

Janaswamy S, Gill KL, Campanella OH, Pinal R.

Carbohydr Polym. 2013 Apr 15;94(1):209-15. doi: 10.1016/j.carbpol.2013.01.008. Epub 2013 Jan 11.

7.

Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data.

Gill KL, Gertz M, Houston JB, Galetin A.

Drug Metab Dispos. 2013 Apr;41(4):744-53. doi: 10.1124/dmd.112.050294. Epub 2013 Jan 9.

8.

Supplemental Content

Support Center